Clinical trial
Understanding Substrate Evolution in Persistent Atrial Fibrillation to Develop Tailored Ablation Strategies
NCT07047235 is registered in ClinicalTrials.gov with Barts & The London NHS Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding Substrate Evolution in Persistent Atrial Fibrillation to Develop Tailored Ablation Strategies
- Lead sponsor
- Barts & The London NHS Trust
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 7, 2025
- Completion date
- August 18, 2030
- Enrollment
- 160 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atrial fibrillation (af), atrial fibrillation mechanisms, catheter ablation, low voltage areas